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Abstract 
The p53 family of transcription factors has been implicated in many vertebrate cancers.  
Altered p53 and p73 protein expression observed in leukemic cells of mollusks suggests that these 
transcription factors might be involved in invertebrate cancers as well. Here, we fully characterize 
the mRNA of four novel p53-like variants in the bivalve mollusks Mytilus trossulus (bay mussel) 
and Mytilus edulis (blue mussel).  These species, widely used for environmental assessment, 
develop a haemic neoplasia (leukemia) that is frequently fatal.  The correlation between expression 
of p53 and its close relative p73 and onset of molluskan leukemia was documented previously.  
We report the sequences of two distinct and novel p63/p73-like mRNAs, amplified by polymerase 
chain reaction (PCR) from both species.  One of the p63/p73-like isoforms contains a 360 nt 
truncation in the 5' coding region.  Based on this truncation and concomitant lack of a trans-
activation (TA) domain, we designate this variant as a DeltaNp63/p73-like isoform: the first to be 
reported in an invertebrate species.  In mammalian species, DeltaNp73 potently inhibits the tumor-
suppressive function of p73 and p53, and its over-expression serves as a robust marker for 
mammalian cancer. 
In addition, we report on the occurrence of alternate polyadenylation sites in the molluskan 
p63/p73: one proximal and one distal site, which differ by 1260 nt. We hypothesize that 
differential expression of various molluskan p63/p73-like isoforms, controlled in part by 
polyadenylation site choice variation, may help to interpret the apparently opposing roles of this 
gene in the development of cancer. Overall, this research further illustrates the utility of the 
molluskan model for studies involving the molecular mechanisms of oncogenesis in naturally 
occurring populations. 
The data presented here require a revisiting of hypotheses regarding evolution of the p53 
gene family.  Current hypotheses indicate that 1) the protostome gene family does not contain an 
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intronic promoter for DeltaN expression and 2) p53 gene duplication did not occur in protostomes.  
Our characterization of DeltaN p63/73 in mussel suggests that molluskan p53 gene family 
members have acquired an intronic promoter or splicing mechanism, either by invention that 
predates the evolutionary split of deuterostoms from protostomes, or by parallel evolution.  Our 
data also show that Mytilus p53, p63/p73 and DeltaNp63/p73 are identical in their core regions 
with variation limited to their C- and N-terminals.  This supports the notion that alternative 
splicing, intronic promoter usage and polyadenylation site choice may lead to expression of 
distinct isoforms originating from one common gene. 
 
 3
1. Introduction 
Mussels and other shellfish are increasingly used for environmental monitoring in fresh 
water and marine environments due to their abundance, sessile nature and filter-feeding habits.  
They are susceptible to carcinogens and can develop a neoplastic disease of the haemolymph 
(leukemia) (Mix 1983) which occurs, at least in part, in response to environmental stressors 
(Reinisch et al., 1984; Farley et al., 1991; McGladdery et al., 2001; St-Jean et al., 2005).  The p53 
family of transcription factors, highly conserved across distantly related species, is implicated in 
vertebrate tumorigenesis (Concin, et al. 2004, Uramoto et al., 2004) as well as in molluskan 
leukemia.  Specifically, p53 and p73 protein expression is altered in the clam Mya arenaria when 
affected by haemic neoplasia (Kelley, et al. 2001; Stephens, et al. 2001).  Similarly, p73 protein is 
expressed at higher levels in leukemic haemocytes of Mytilus edulis (St-Jean, et al. 2005). 
The functional domains of the p53 family of proteins across species are: an acidic amino-
terminal transactivation domain (TA), several DNA-binding domains (DBD), and a carboxy-
terminal oligomerization domain (OLIGO).  In contrast to p53, p63 and p73 undergo multiple 
post-transcriptional processes that generate distinct classes of proteins, some of which lack the N-
terminal TA domain.  For p63 and p73, the carboxyl terminus undergoes alternate splicing, 
yielding several products which may or may not contain a sterile alpha motif (SAM), a 
homodimerization domain (HOMO) (Jessen-Eller, et al. 2002), and a sumoylation site (SUMO) 
(Minty et al., 2000; Strano et al., 2001; Moll and Slade, 2004). 
Well established as key elements in mammalian neuronal and epidermal development, p73 
and p63, respectively, respond to DNA damage by controlling apoptosis and cell cycle arrest (Moll 
and Slade 2004).  The NH2-terminal lacking p63 and p73 isoforms, DeltaN, are upregulated in 
some cancers (Concin et al., 2004), and are known to suppress the tumor-repressive function of 
p53, p63 and p73 (Ishimoto et al., 2002).  Here, we report on the first N-terminal variant of a 
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p63/p73-like cDNA from any invertebrate species.  Our findings show that the molluskan bivalves 
Mytilus edulis and Mytilus trossulus contain an N-terminally truncated isoform that is homologous 
to vertebrate DeltaN p63 and p73.  Since the N-terminal isoform is already in use as a marker for 
mammalian cancer (Uramoto et al., 2004),  discovery of a Delta N p53-like isoform in Mytilus sp. 
enables research into the expression levels of this variant and its potential involvement in haemic 
neoplasia in these species.  
In addition, this report describes and characterizes 3’UTR variants of the p63/p73-like 
mRNA in these two molluskan species.  We hypothesize that these variants represent tandem 
alternate polyadenylation sites, also identified in another bivalave mollusk S. solidissima p63/p73 
(Cox et al., 2003).  Alternate polyadenylation site choice variation is widely employed and well 
characterized in mammalian species. Site choice variation controls gene expression in a tissue- or 
developmental stage-dependent manner (Edwards-Gilbert et al., 1997; Tian et al., 2005).  This 
process should be carefully distinguished from alternative splicing, a well documented process that 
occurs in the p53/p63/p73 gene family.  The molluskan p63/p73 3’UTR site choice variants 
described here may potentially affect mRNA stability, translatability and transport.  Identification 
of these 3’ UTR variants suggest that alternate polyadenylation of p63/p73 may act as an important 
post-transcriptional regulatory event. However, further experimentation involving in vivo 
monitoring of these variants is required before their roles in control of p53 family expression are 
known.   Further, we hypothesize that the occurrence of 3’UTR control of p63/p73 gene 
expression in mollusks may be an alternate mechanism for variability in protein expression that is 
similar to, but distinct from that which has developed in mammalian species. 
A question that remains unanswered is whether the molluskan p53 and p63/p73s are coded 
for by multiple genes, as in mammals (Moll et al., 2001), or whether these homologues represent 
variants of a single ancestral gene.  Based on our phylogenetic analysis of p53, p63 and p73 cDNA 
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sequences from diverse species and alignments of Mytilus p53, p63/p73 and DeltaNp63/p73 
putative proteins we hypothesize that the invertebrate p53 and p63/p73  isoforms may originate 
from a single gene.  This is in contrast to vertebrate p53, p63 and p73 isoforms where gene 
duplication has taken place. 
 
2. Materials and Methods 
2.1. Samples and mRNA extraction 
M. trossulus were collected in November 2004 at Jericho Beach, Vancouver, British 
Columbia. M. edulis were collected in February 2005 at Buzzards Bay, Woods Hole, 
Massachusetts. M. trossulus gills were excised and immediately immersed in 1.5 ml RNA Later 
(Ambion Inc., Austin, TX), kept at 4oC overnight, then frozen at –20oC, and shipped on dry ice for 
RNA extraction to the Woods Hole Marine Biological Laboratory.  Total RNA was extracted 
using Trizol reagent (Invitrogen Corp., Carlsbad, CA) following manufacturer instructions.  M. 
edulis gills were excised and immediately transferred to 2 ml Trizol for total RNA extraction.  
RNA from each species was re-suspended in DEPC-treated water and stored at –80oC. mRNA was 
concentrated from three pooled gill total RNA extracts using Qiagen Oligotex mRNA maxi kit 
(Qiagen GmbH, Hilden, Germany).  
 
2.2. Species identification 
DNA was retained during the Trizol extraction procedure from each of the six mussel gill 
samples and re-suspended in 0.7 to 1.4 ml of 8 mM sodium hydroxide.  The internal transcribed 
spacer (ITS) region of the ribosomal RNA genes was amplified using a method developed by 
(Heath et al., 1995) with the following modifications: 1 μl of template DNA was amplified in a 
25 μl-reaction containing 2 mM MgCl2, 5 mM each ITS primer (Table 1) and 1 U Taq polymerase 
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(Invitrogen).  Thermal cycling was performed as follows: 94oC for 10 min, 10 cycles of 94oC for 
30”, 53oC for 30”, 72oC for 1’, 20 cycles of 94oC for 30”, 55oC for 30”, 72oC for 1’, and final 
extension for 7’ at 72oC. 5 μl of the PCR reaction was transferred to a fresh reaction tube and 
supplemented with 7.5 μl dH2O, 1.5 μl React 2 buffer and 1 μl HhaI enzyme (Invitrogen).  This 
mix was incubated for one hour at 37oC and the reaction was heat-inactivated for 5’ at 65oC.  5 μl 
of this enzymatic digestion and 5 μl of the remaining PCR reaction were analyzed by gel-
electrophoresis (2.5 % agarose) and ethidium bromide staining. 
 
2.3. cDNA synthesis, polymerase chain reaction (PCR) with degenerate primers, cloning and 
sequencing 
cDNA was synthesized from 1 μg mRNA using PowerScriptTM Reverse Transcriptase (BD 
Biosciences Clontech, Palo Alto, CA) and 500 ng oligo-dT(12-18) primer following the 
manufacturer’s instructions. Initial amplification of a p73 transcript was performed on cDNA 
using forward primer pMe-1F, based on the p53 sequence of M. edulis (Muttray et al., 2005) and 
degenerate reverse primer pDeg-p73R(1698-1716) designed here to match the SAM domain of 
aligned vertebrate and invertebrate p73 protein sequences (Figure 2A). PCR was carried out in a 
step-up fashion starting at an annealing temperature of 30oC, increasing by two degrees every two 
cycles, with a final annealing temperature of 44oC for 25 cycles. Melting at 94oC for 30 sec., 
annealing for 30 sec., extension at 72oC for 1.5 min., with a final extension step for 7 min. The 
resulting 1.6 kb-PCR product was re-amplified from a gel stab and the resulting band was purified 
using the High Pure PCR product purification kit (Roche Diagnostics GmbH, Mannheim, 
Germany), ligated into pCR®2.1-TOPO® and cloned into E. coli TOP10 cells using the TOPO TA 
cloning kit (Invitrogen Corp., Carlsbad, CA). Colonies were screened by PCR with M13 F (-20) 
and M13 R primers (30 cycles, annealing temperature of 55oC) and positive clones were grown 
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overnight in Luria Broth with ampicillin (100 μg/ml). Plasmid DNA was extracted using the 
Plasmid Mini kit (Qiagen, Inc., Valencia, CA), and submitted for sequencing.  
 
2.4. Rapid amplification of cDNA ends (RACE-PCR) and final PCR 
3’ and 5’-RACE-ready cDNA was produced using the BD SMARTTM RACE cDNA 
amplification kit and manufacturer’s instructions. Several gene-specific primers were designed 
based on the sequence obtained from the degenerate PCR and used in semi-nested 3’ and 5’ Smart 
RACE PCR reactions using the BD Smart RACE cDNA amplification kit (BD Biosciences 
Clontech) (Table 1, Figure 2A). An annealing temperature of 68 oC was used for 30 cycles. 
Several consistent 5’RACE and 3’RACE PCR products of different lengths were gel-purified, 
cloned and sequenced as described above. Resulting sequences were used to design primers for 
full-length amplification of putative p63/p73 and DeltaNp63/p73 variants (Table 1, Figure 2A). 
Full-length PCR amplification was performed using a touch-down PCR protocol, where the 
annealing temperature was decreased by 0.5 degrees each cycle, starting at 65 oC, with a final 
annealing temperature of 55 oC, for a total of 35 cycles. Primer extension was performed at 72 oC 
for 3 minutes.  
 
2.5 Amino acid sequence analysis 
Mytilus p63/p73-like deduced amino acid sequences were submitted to protein-protein 
BLAST searches. We performed pair wise multiple amino acid alignment of the deduced Mytilus 
p53, p63/p73 protein isoforms with selected species using ClustalX 1.83 (Jeanmougin et al., 1998) 
(residue substitution matrix Gonnet) to illustrate conserved protein domains. Gap opening penalty 
was set to 10; gap extension penalty at 0.1. The alignment was viewed in Boxshade 3.21 and 
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edited in Word (Microsoft, Redmond, WA) in order to match known highly conserved regions of 
the protein. The species and accession numbers are listed in Table 2.  
 
2.6 Phylogenetic nucleic acid sequence and 3’UTR analyses  
Full-length cDNA sequences of Mytilus and other known p53, p63 and p73 (Table 2) were 
aligned using ClustalX 1.83.  Gap opening penalty was set to 15; gap extension penalty at 6.66.  
The phylogenetic tree was produced in ClustalX, bootstrapped 200 times and displayed using 
TreeView (Page, 1996).  Protein sequence identities were obtained from TreeView.  The 3’UTR 
cDNA sequences, variant A and B from M. edulis were aligned in ClustalX 1.83.  Potential 
signaling motifs (PAS hexamer and upstream efficiency elements) were identified by hand. 
 
3. Results and Discussion 
3.1. Characterization of p63/p73-like  isoforms in M. trossulus and edulis 
The identities of the mussel species were confirmed by ITS PCR and RFLP with HhaI 
(Heath et al., 1995).  Each of the three M. trossulus gill DNA samples showed three bands at 180, 
>200 and 280 nt, while each of the three M. edulis gill DNA samples showed a doublette at 
approximately 180 and 200 nt and a third band at 480 nt (Figure 1).  This result compares well 
with results obtained previously by Heath et al. (1995) taking into account paired bands that cannot 
be completely resolved by standard agarose electrophoresis. 
RNA extracts from the three individuals of each species were combined for mRNA 
extraction and RACE PCR. Four new p53 family variants were identified per species (GenBank 
accession numbers in Table 2).  Sequence analysis of these variants revealed them to be more 
similar to p63 or p73 than p53 due to a significantly longer C-terminal region which contains a 
sterile alpha motif (SAM), a protein-protein binding domain previously identified in mammalian 
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p63 and p73.  Thus we refer to them as p63/p73-like isoforms. The full-length cDNAs for M. 
edulis and trossulus TAp63/p73 and DeltaNp63/p73-like isoforms were identified from cDNA 
from the combined gill tissue RNA extracts.  Figure 2B shows the PCR products by ethidium 
bromide-stained agarose gel electrophoresis.  The size variability in the cDNAs is due to the size 
differential between the 5’ variants (TA and DeltaN), which differ by 360 bp, and between the 3’ 
alternate polyadenylation site choice variants (A and B), which differ by 1260 bp. The full-length 
cDNA sequences were translated into putative protein sequences. The DeltaN isoforms of M. 
edulis and M. trossulus, termed MedNp63/p73-like and MtdNp63/p73-like, respectively, are 122 
amino acids (aa) shorter at the N-terminus than the TA isoforms (Mep63/p73 and Mtp63/p73) 
(Figure 3).  This is a greater difference in length than in human (43 aa) or mouse (40 aa), but is 
strictly dependent on the choice of the start codon and could be as short as 58 aa. TA and DeltaN 
isoforms are conserved throughout the remainder of the open reading frame (ORF). 
5’RACE experiments revealed that there are three possible start sites in the TA isoforms (at 
aa 1, 35 and 56) prior to the TA domain, while the DeltaN isoforms only have one start site 
initiating the ORF.  The N-terminus of Mytilus p63/p73 may be considerably longer than in other 
species, depending on selection of translation start sites.  None of the potential start codons have a 
conserved “Kozak” sequence, although aa residues 35 and 56 are preceded by an A at –3 base 
position and could therefore be considered stronger translation initiation sites than aa 1.  The 
putative protein sequences are highly conserved between M. edulis and M. trossulus (99% 
similarity), except for three positions: Threonine in M. edulis is replaced with serine in M. 
trossulus at position 142, and serine and threonine are inserted at aa positions 483 and 484 in M. 
edulis.  This is a similar amino acid sequence conservation to previously reported p53 sequences 
between the two species (Muttray et al., 2005).  The complete cDNA sequences are less conserved 
than the protein sequences between the two species: 97 % for the coding regions of both isoforms, 
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and 80-82 % including the coding region and 3’UTR of both isoforms.  The calculated molecular 
mass of the putative DeltaN protein isoform is 60 kDa, and of the TA isoform 73 kDa. 
We performed a comparative analysis between the four Mytilus p63/p73-like deduced 
protein isoforms and representatives of other major lineages: Mya arenaria and Spisula solidissima 
p63/p73 were chosen as representatives for bivalve mollusks and likely close relatives of Mytilus, 
and two well-characterized vertebrate mammalian representatives, Homo sapiens and Mus 
musculus (Figure 3).  The Mytilus p63/p73 sequences are most closely related to Mya arenaria p73 
(57 % similarity) and Spisula solidissima p63/p73 (55 % similarity), and only distantly related to 
H. sapiens and M. musculus p73 (27-31 % similarity). These are slightly lower similarity values 
than was observed previously for p53 for some of these species (Muttray et al., 2005).  
 
3.2 Analysis of p63/p73-like domains 
This is the first report of an N-terminal isoform of p63 or p73 in invertebrates. The DeltaN-
like isoforms in Mytilus lack the transcriptional activation (TA) domain of the TA-like isoforms, as 
has previously been described in vertebrate p63 and p73 (Figure 3).  The p63/p73 TA domain is 
highly conserved between species and likely provides the binding site for proteins regulating p53, 
p63 and p73 activity.  The N-terminus of the Mytilus p63/p73-like isoform is 55 aa longer than the 
N-terminus of the previously identified p53 isoform (Muttray et al., 2005) (see p53 start site in 
Figure 3). Following the TA domain is a highly diverse proline-rich region containing two PxxP 
motifs potentially involved in apoptosis and binding of SH3-containing kinases involved in signal 
transduction (Kelley et al., 2001).  It was shown that p73 and a non-receptor tyrosine kinase 
involved in the response to DNA damage, c-Abl, interact at a PxxP domain between the DNA 
binding domains (DBDs) and oligomerization domain (OLIGO) domains in humans (reviewed in 
Melino, 2003).  However, this PxxP is not conserved in mollusks.  There are four DBDs positioned 
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between aa 211 and 379.  These DBDs are highly conserved between species, such as 93 % 
similarity with M. arenaria and S. solidissima p63/p73.  Based on protein BLAST searches we 
found 63 % and 59 % similarity with H. sapiens and other vertebrate p63 and p73, respectively.  
Based on this result, the Mytilus isoforms may be more p63-like than p73-like, but a final 
conclusion about their identities cannot be reached until their protein function is characterized.  
Thus far, mammalian p63 isoforms have been indicated predominately in embryonic epithelial 
development, but also in human leukemia (Yamaguchi et al., 2001; Nakamura et al., 2004; 
Bernassola et al., 2005).  Using an antibody to the homology (HOMO) domain (Cox et al., 2003), 
it was shown that p63/p73-like proteins were more highly expressed in leukemic than in normal 
haemocytes of mussels (St-Jean et al., 2005).  
As shown in Figure 3, the OLIGO domain is located at aa positions 425 to 457, followed 
by a divergent block of sequence.  The C-terminus contains the sterile alpha motif (SAM), and a 
tetramerization domain with HOMO and sumoylation (SUMO, small ubiquitin-like modifier) 
domains, as was previously found in other invertebrates (Jessen-Eller et al., 2002; Cox et al., 
2003).  A prototypical SUMO domain was characterized in p53, p63 p73 and other proteins as the 
terminal lysine residue preceded by a hydrophobic amino acid and glutamic acid at position +2 
(mammalian cell lines; (KXE/D)) (Minty et al., 2000).  Here, we observe two potential SUMO 
sites: First, a terminal lysine 715 preceded by a hydrophobic amino acid (alanine) and glutamic 
acid at +2 present only in Mytilus, and second, a lysine 706 preceded by a hydrophilic threonine 
and aspartic acid at +2 present in all shown bivalves (solid border, Figure 3).  
In mammalian p73, the terminal lysine motif has been shown to interact with SUMO-1, 
which potentiates proteasomal degradation of p73 (Minty et al., 2000).  Sumoylation 
characteristically adds ~20 kDa to the molecular weight of the protein which was observed in 
SDS-PAGE on Spisula p63/p73 using the HOMO domain antibody (Cox et al., 2003). 
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An alternative SUMO motif has been identified in novel SUMO-1-interacting proteins, 
containing a central SXS (or SXT) triplet preceded by predominantly hydrophobic amino acids and 
followed by predominantly acidic amino acids (Minty et al., 2000).  The serine/threonine and 
acidic residues essential for the interaction constitute a double CKII kinase site [(S/T)XX(D/E)], 
and thus the interaction may be regulated by phosphorylation. Interestingly, the second potential 
Mytilus alternative SUMO site (aa 703, Figure 3, dotted border) also contains the (SXTXXD) motif 
and may thus be relevant for an alternate sumoylation pathway in Mytilus. 
 
3.3 Phylogenetic analysis of p53, p63 and p73 in invertebrates and vertebrates 
The overall structure and sequence homology in the p53 family indicates that p53, p63, and 
p73 evolved from a common ancestor (Melino et al., 2002).  This ancestor has been described as 
resembling a p63 containing a SAM domain (Yang et al., 2002).  Our BLAST searches with the 
putative Mytilus p63/p73 also indicate that the mollusk DBDs are most similar to mammalian p63 
indicating that the mollusk gene(s) are more closely related to the ancestral p63+SAM.  The 
question remains as to whether distinct p53, p63 and p73 gene sequences will be characterized in 
invertebrate species and whether these genes will be mapped to separate chromosomes, or whether 
p53, p63 and/or p73 are splice variants of one gene.  Gene duplication removes the pressure of 
natural selection from one copy of the duplicated gene and allows this copy to mutate more freely 
and potentially acquire new functions. If gene duplication had occurred in mollusks one would 
expect core regions to deviate from the ancestral p63.  In fact, mollusks (cambrian, 570 M years) 
are evolutionary older than vertebrates (ordovizium, 500 M years) and hence the core cDNA 
regions should be more diverse in mollusks than in vertebrates.  We performed two alignments: a 
multiple alignment of putative p53, p63/p73 and DeltaNp63/p73 proteins from M. edulis (Figure 4) 
and a multiple pair wise alignment and phylogenetic tree construction with cDNAs of available 
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vertebrate and invertebrate p53, p63 and p73 (Figure 5).  M. edulis p53, p63/p73 and 
DeltaNp63/p73 proteins show identical core sequences containing DBDs II to V, NLS, and 
OLIGO domains (Figure 4).  The three putative proteins differ only in their C- and N-terminals, 
suggesting that alternative splicing and intronic promoter usage could lead to expression of three 
different p53, p63 and p73-like isoforms from one common gene.  Similarly, Mya arenaria p53 
and p73 exhibit identical core regions (Kelley et al. 2001), and Southern blot analysis using a 
probe against the DBD IV region indicated the presence of only one gene (van Beneden et al. 
1997).  Figure 5 (second alignment) shows that invertebrate mollusk p53 and p63/p73 cluster in 
one branch according to species, while vertebrate p53, p63, and p73 are on distinct branches and 
cluster according to isoform rather than species.  Both alignments support earlier hypotheses 
(Yang et al., 2002; Cox et al., 2003) that invertebrate p53-like isoforms thus far identified are 
likely splice variants of the same gene, rather than products of distinct genes, as is the case for 
vertebrates where gene duplication has taken place.  However, Yang et al. also hypothesized that 
the invertebrate-to-vertebrate transition led to the acquisition of a dual promoter structure that 
yields TA and DeltaN isoforms of p63 and p73.  With the isolation of a putative DeltaN isoform of 
p63/p73 from Mytilus, we now revise this hypothesis and suggest that internal splicing or the 
‘invention’ of an intronic promoters in the p53-family has either preceded gene duplication in 
phylogenetically more recent organisms and is of far more ancient origin than was previously 
thought, or that it is the result of parallel evolution in both vertebrates and invertebrates.  An 
internal promoter and N-terminal splicing was also recently identified for Drosophila p53 
(Bourdon et al., 2005) which results in two possible p53 isoforms containing either a full-length or 
truncated TA domain. However, the two Drosophila p53 isoforms did not contain the SAM 
domain that differentiates p53 from p63 and p73 in the vertebrate and the tentative molluskan p53 
family. 
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The Drosophila (and C. elegans) genomes have diverged more from the ancestral genome 
than vertebrate lineages due to high rates of molecular evolution and secondary gene loss 
(Kortschak et al., 2003; Raible and Arendt, 2004).  Unlike flies and nematodes, other invertebrates 
(including mollusks) seem to have retained more of the ancestral urbilaterian gene inventory as 
well (Raible and Arendt, 2004).  The isolation of a DeltaN isoforms in Mytilus also suggests that 
the mollusks are well-suited model systems for the study of p53/p63/p73-family gene regulation, 
especially in regards to embryonic development and tumorigenesis as over-expression of DeltaN 
isoforms may contribute to the genesis of tumors by negating the tumor-suppressive activity of p53 
or TAp73 (Ishimoto et al., 2002; Concin et al., 2004).  Western blot analysis with antibodies 
against the Spisula p63/p73 HOMO domain showed a higher concentration of a protein less than 
66 kDa in size in leukemic haemocytes in Mytilus when compared to normal haemocytes (St-Jean 
et al., 2005).  Based on our results, this protein may be a DeltaN isoform (predicted 60 kDa, see 
above) rather than a TA isoform (predicted 73 kDa). 
 
3.4 3’UTR analysis 
Using PCR, we amplified two distinct full-length cDNA sequences (including 
3’untranslated regions up to the poly A tail) for each Mytilus p63/p73-like isoform (Figures 2 and 
3).  These 3’UTR variants are similar to site choice variants identified by Cox, et al. (2003) for the 
Spisula p63/p73 gene, and clearly distinct from the C-terminal splice variants reported for 
vertebrate p63 and p73.  An alignment of the 3’UTRs (Figure 6) reveals that the Mytilus p63/p73-
like isoform contains two alternate polyadenylation (proximal and distal) sites.  This is the case for 
each N-terminal isoform for each species.  Figure 6 represents the 3’UTR site variants for the 
Mep63/p73-like isoform only.  We designate these as tandem polyadenylation site choice variants 
and refer to them as variant A (proximal) and variant B (distal).  A sequence comparison of the 
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polyadenylation site variants shows minor divergence, mainly in the region of the proximal poly-A 
tail (Figure 6).  In general, when comparing the 3’UTR sequences, we found minor species-
specific differences, but no difference between isoforms within an individual species. 
Well documented in mammalian genes, alternate polyadenylation site choice gives rise to 
different mRNAs and thus to distinct protein products, that are often associated with specific tissue 
expression or developmental stage (Edwards-Gilbert et al., 1997).  The choice of a particular 
polyadenylation site is thought to involve 3’ signaling elements, such as the polyadenylation 
signals (PAS) hexamers with the sequence AATAAA (or close variants ATTAAA, TTTAAA) that 
are located within 40 nucleotides of the cleavage site.  In addition, phylogenetically conserved 
elements upstream of PAS, known as upstream efficiency elements (USEs) are known to enhance 
polyadenylation efficiency and mRNA processing (Moreira et al., 1998).  Figure 6 shows that both 
site choice variants contain potential PAS signals within 30 nts of the poly-A tail, suggesting that 
both variants are in use, possibly under different cell conditions.  One PAS hexamer in the 
proximal variant A falls at a greater distance than 40nts from the poly A tail.  This was also shown 
to be the case in bivalve molluskan p73 3’UTR sequences, the soft shell clam Mya arenaria 
(Kelley et al., 2001) as well as the surf clam Spisula solidissima (Cox et al., 2003).  In addition, 
while both proximal and distal variants contain two potential USEs, (ATTTGAA and 
ATTTCTTA), their proximity to the polyadenylation site in variant A (proximal) indicates that this 
variant may be more stable. 
Recently referred to as a “molecular hotspot for pathology” (Conne et al., 2000), the 
3’UTR has a major influence on the regulation of gene expression. Polyadenylation site choice can 
change enormously the outcome of the translated protein product in terms of its stability and size. 
What implications these polyadenylation site choice variants have on the expression of p53-family 
proteins in Mytilus sp. still needs to be determined. 
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 4. Conclusions 
1) Four new p53-family cDNA sequences, designated TAp63/p73 A (and B) and 
DeltaNp63/p73 A (and B), were identified in two closely related mussel species, M.  edulis 
and M.  trossulus. The new sequences were found to be more similar to p63 or p73 than 
p53 (Muttray et al., 2005) due to a C-terminal SAM domain. One sequence lacked the TA 
domain and was designated DeltaNp63/p73-like. Two polyadenylation site choice variants 
were identified. 
2) Phylogenetic analysis of p53, p63 and p73 cDNA sequences from invertebrate and 
vertebrate species suggests that the putative p53 family proteins identified in M.  trossulus 
and edulis may be coded from one gene.  This is in contrast to vertebrate species where 
gene duplication and diversification have occurred.  Molluskan p53-like isoform 
nomenclature is preliminary.  
3) This is the first report of an invertebrate DeltaNp63/p73-like isoform. This revises earlier 
hypotheses and infers that the invention of a dual promoter or alternate splicing for the 
expression of TA and DeltaN isoforms pre-dates gene duplication within the p53 gene 
family in more recent lineages, or that parallel evolution has occurred. 
4) As we reported previously in other molluskan species, Mytilus TA and DeltaNp63/p73 
contain alternate 3’UTRs that may represent functional alternate polyadenylation site 
choice variants.  Site choice variation may have arisen as a post-transcriptional point of 
control for variable gene expression in this ancestral form of the p53 gene family. 
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Figures and Tables 
 
Figure 1: 
Species determination based on ITS PCR and RFLP for six Mytilus gill samples used for RNA 
extraction, on 2.5 % agarose. Lanes 1-6, PCR amplicons of the internal transcribed spacer (ITS) 
region between the 18S and 28S ribosomal RNA genes; 7, no template control; 8-13, HhaI digest 
of PCR amplicons; 1-3 and 8-10, M. trossulus from Jericho Beach, Vancouver, BC; 4-6 and 11-13, 
M. edulis from Buzzards Bay, Woods Hole, MA. The marker lanes contain the 100 bp ladder. 
 
Figure 2: 
Isolation of p63/p73-like isoforms in Mytilus.  A;  Primers used in the amplification strategy of 
p63/p73-like isoforms in M. trossulus. All four identified isoforms are shown. Functional domains 
(TAD, DBD, SAM, and 3’UTR) are not to scale. Corresponding primer sequences are listed in 
Table 1.  B;  RT-PCR amplification products of M. trossulus mRNA extracted from gills by gel 
electrophoresis on a 1 % agarose gel followed by ethidium bromide staining. PCR was carried out 
using the primers indicated in Table 1. For cycling parameter, see Materials and Methods. 
 
Figure 3: 
Multiple pair wise alignment of deduced amino acid sequences for TA- and DeltaNp63/p73 or p73 
isoforms from M. edulis, M. trossulus, Mya arenaria, Spisula solidissima, Homo sapiens and Mus 
musculus. Color coding: black on white, non-homologous residues; green on white, weakly similar 
residues; blue on white, block of identical residues; red on gray, block of conserved residues. 
Residues distinguishing the two Mytilus species are shown on dark-gray background. TAD, DBD, 
NLS, OLIGO, SAM, HOMO domains and SUMO recognition sites are indicated. Manual 
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adjustments were made to align vertebrate and deduced invertebrate SUMO sites. The TI 
(tetramerization) domain is indicated by a red dashed line, and proline-rich regions are indicated 
by ‘PxxP’. The start site of p53 in Mytilus is indicated with an arrow. Species and accession 
numbers are listed in Table 2. 
 
Figure 4: 
Multiple pair wise alignment of putative M. edulis p53, TAp63/p73 and DeltaNp63/p73 protein 
isoforms using ClustalW 1.8. Core regions are identical (*), while the C- and N-termini vary.  
 
Figure 5: 
Invertebrate p53 and p73-like orthologues cluster closely in one branch according to species, while 
vertebrate p53, p63 and p73 cluster in separate braches according to p53-family member. The 
unrooted neighbor-joined consensus tree was based on a pair wise ClustalW 1.8 alignment of 
nucleic acid sequences and bootstrapped 200 times. Numbers at the nodes indicate bootstrap 
values. The bottom scale measures genetic distances in substitutions per nucleotide. See Table 2 
for species list and abbreviations. 
 
Figure 6:  
A. Schematic representation of p63/p73–like mRNA from Mytilus showing tandem 
polyadenylation site choice variants proximal (A) and distal (B). 
B. M. edulis p63/p73 3’ UTR regions, showing tandem polyadenylation site variants.  Each 
sequence begins with the TGA stop site and ends with the poly A tail (in italics).  Putative PAS 
hexamers are underlined.  Putative USEs are highlighted in grey. 
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Table 1:  
Primers used in the identification of Mytilus TA- and DeltaNp63/p73. “A” denotes short proximal 
transcripts utilizing the first alternate polyadenylation site, while “B” denotes long distal 
transcripts utilizing the second alternate polyadenylation site. 
 
Table 2: 
Species names, abbreviations, accession numbers of sequences generated in this publication or 
used for phylogenetic comparisons. Phylogenetic taxa are indicated. 
 
 
 
 
Figure 1 
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3054 bp 
4072 bp 
3’ variations 
(1260 bp) 
5’ variations 
(360 bp) 
             p53 start  TA 
Mep63/p73    MNGDLHNTPQVPIWNSRPDPRLNYLRSQGYNNYNMPSHNYNPGCRFGKFTHHHPIMSQASVSTTCTPSGPPMSQETFEYLWNTLGEVTQEGG 
MedNp63/p73  -------------------------------------------------------------------------------------------- 
Mtp63/p73    MNGDLHNTPQVPIWNSRPDPRLNYLRSQGYNNNSMPSHNYNPGCRFGKFTHHHPIMSQASVSTTCTPSGPPMSQETFEYLWNTLGEVTQEGG 
MtdNp63/p73  -------------------------------------------------------------------------------------------- 
Map73        -------------------------------------------------MSHEALHKMSQVAIHGTPPNQPMSQETFEYLWHTLEEVTDNVD 
Ssp73        ---------------------------------------------------------MSEVST-ATPPNAPMSQDTFEYLWNTLESVTDNGT 
Hsp73a       --------------------------------------------------------------MAQSTATSPDGGTTFEHLWSSLEPDSTYFD 
HsdNp73a     -----------------------------------------------------------------------------------------MLY 
Mmp73a       -----------------------------------------------------------------MAQTSSSSSSTFEHLWSSLEPDSTYFD 
MmdNp73      ---------------------------------------------------------------------------------------MLYVG 
             1........10........20........30........40........50........60........70........80........90. 
 
               PxxP 
Mep63/p73    YTNITSKESIDYAFSEAEDETSISVEKYRIT-SNDSISDLLNPIIGQTTTASSMSPDSQTNIIGSSASSPYND-TITSPPPYSPHTSMQSPI 
MedNp63/p73  ---------------------MIKFERTGFT-TYR-----LNPIIGQTTTASSMSPDSQTNIIGSSASSPYND-TITSPPPYSPHTSMQSPI 
Mtp63/p73    YTNITSKESIDYAFSEAEDETSISVEKYRIT-SNDSISDLLNPIIGQTTSASSMSPDSQTNIIGSSASSPYND-TITSPPPYSPHTSMQSPI 
MtdNp63/p73  ---------------------MIKFERTGFT-TYR-----LNPIIGQTTSASSMSPDSQTNIIGSSASSPYND-TITSPPPYSPHTSMQSPI 
Map73        YTHINTRE-LDYSYDDSEDGTSLQVEKFRINQHHTDVSDPLNPIIGTTSS-SSMSPDSQTNISGSTASSPYQEMALTSPPPYSPHTNLTSPI 
Ssp73        YTQINSRD-LDYSYEDSDEGASLHIDKFRI--HGNDVSDLLNPIIGTSSSPSSMSPDSQTNIICSTASSPYHEGTLTSPPPYSPHTNMTSPI 
Hsp73a       LPQSSRGNNEVVGGTDSSMDVFHLEGMTTSV--MAQFNLLSSTMDQMSSRAASASPYTPEHAASVPTHSPYAQ--------PSSTFDTMSPA 
HsdNp73a     VGDPAR----------------HLA--------TAQFNLLSSTMDQMSSRAASASPYTPEHAASVPTHSPYAQ--------PSSTFDTMSPA 
Mmp73a       LPQPSQGTSEASGSEESNMDVFHLQG-------MAQFNLLSSAMDQMGSRAAPASPYTPEHAASAPTHSPYAQ--------PSSTFDTMSPA 
MmdNp73      DPMRHLAT--------------------------AQFNLLSSAMDQMGSRAAPASPYTPEHAASAPTHSPYAQ--------PSSTFDTMSPA 
             .......100.......110.......120.......130.......140.......150.......160.......170.......180.. 
 
             PxxP    DBD II      DBD III 
Mep63/p73    PSVPSNTDYPGDYGFTISFSQPSKETKSTTWTYSESLKKLYVRMATTCPIRFKCLRQPPQGCVIRAMPIFMKPEHVQEPVKRCPNHATSKEH 
MedNp63/p73  PSVPSNTDYPGDYGFTISFSQPSKETKSTTWTYSESLKKLYVRMATTCPIRFKCLRQPPQGCVIRAMPIFMKPEHVQEPVKRCPNHATSKEH 
Mtp63/p73    PSVPSNTDYPGDYGFTISFSQPSKETKSTTWTYSESLKKLYVRMATTCPIRFKCLRQPPQGCVIRAMPIFMKPEHVQEPVKRCPNHATSKEH 
MtdNp63/p73  PSVPSNTDYPGDYGFTISFSQPSKETKSTTWTYSESLKKLYVRMATTCPIRFKCLRQPPQGCVIRAMPIFMKPEHVQEPVKRCPNHATSKEH 
Map73        PTVPSNTNYPGDYGFEISFATPSKETKSTTWTYSDILKKLYVRMATTCPVRFKTLRQPPPGCVIRSMPIFMKPEHVQEAVKRCPNHATSKEF 
Ssp73        PTVPSNTNYPGDYGFEISFATPSKETKSTTWTYSDMLKKLYVRMATTCPVRFKTNRQPPAGCIIRSMPIFMKPEHVQEAVKRCPNHATSKEF 
Hsp73a       PVIPSNTDYPGPHHFEVTFQQSS-TAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDF 
HsdNp73a     PVIPSNTDYPGPHHFEVTFQQSS-TAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDVVKRCPNHELGRDF 
Mmp73a       PVIPSNTDYPGPHHFEVTFQQSS-TAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDIVKRCPNHELGRDF 
MmdNp73      PVIPSNTDYPGPHHFEVTFQQSS-TAKSATWTYSPLLKKLYCQIAKTCPIQIKVSTPPPPGTAIRAMPVYKKAEHVTDIVKRCPNHELGRDF 
             .....190.......200.......210.......220.......230.......240.......250.......260.......270.... 
 
          DBD IV   DBD V 
Mep63/p73    NENHPAPT-HLCRCEHK-LAKFVEDPYTSRQSVLIPHEIPQAGSEWVTNLFQFMCLGSCVGGPNRRPIQIVLTLEK-DNQVLGRRAVEVRIC 
MedNp63/p73  NENHPAPT-HLCRCEHK-LAKFVEDPYTSRQSVLIPHEIPQAGSEWVTNLFQFMCLGSCVGGPNRRPIQIVLTLEK-DNQVLGRRAVEVRIC 
Mtp63/p73    NENHPAPT-HLCRCEHK-LAKFVEDPYTSRQSVLIPHEIPQAGSEWVTNLFQFMCLGSCVGGPNRRPIQIVLTLEK-DNQVLGRRAVEVRIC 
MtdNp63/p73  NENHPAPT-HLCRCEHK-LAKFVEDPYTSRQSVLIPHEIPQAGSEWVTNLFQFMCLGSCVGGPNRRPIQIVLTLEK-DNQVLGRRAVEVRIC 
Map73        NENHPAPN-HLVRCEHK-VSKYVEDPYTNRQSVLIPQETPQAGSEWVTNLFQFMCLGSCVGGPNRRPLQIVFTLEK-DNQVLGRRCVEVRIC 
Ssp73        NENHPAPN-HLVRCEHK-LAKYVEDPYTSRQSVVIPQETPQAGSEWVTNLFQFMCLGSCVGGPNRRPLQIVFTLEK-DNQVLGRRCVEVRIC 
Hsp73a       NEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRIC 
HsdNp73a     NEGQSAPASHLIRVEGNNLSQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILIIITLEMRDGQVLGRRSFEGRIC 
Mmp73a       NEGQSAPASHLIRVEGNNLAQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILVIITLETRDGQVLGRRSFEGRIC 
MmdNp73      NEGQSAPASHLIRVEGNNLAQYVDDPVTGRQSVVVPYEPPQVGTEFTTILYNFMCNSSCVGGMNRRPILVIITLETRDGQVLGRRSFEGRIC 
             ...280.......290.......300.......310.......320.......330.......340.......350.......360...... 
 
  DBD V        NLS   OLIGO 
Mep63/p73    ACPGRDRKADEKAA--LPPCKQSPKKGQ---KVNIIN---EITTVTPGGKKRKAEDE--PFTLSVRGRENYEILCRLRDSLELSSMVPQNQI 
MedNp63/p73  ACPGRDRKADEKAA--LPPCKQSPKKGQ---KVNIIN---EITTVTPGGKKRKAEDE--PFTLSVRGRENYEILCRLRDSLELSSMVPQNQI 
Mtp63/p73    ACPGRDRKADEKAA--LPPCKQSPKKGQ---KVNIIN---EITTVTPGGKKRKAEDE--PFTLSVRGRENYEILCRLRDSLELSSMVPQNQI 
MtdNp63/p73  ACPGRDRKADEKAA--LPPCKQSPKKGQ---KVNIIN---EITTVTPGGKKRKAEDE--PFTLSVRGRENYEILCRLRDSLELSSMVPQNQI 
Map73        ACPGRDRKADERGS--LPPMVSGGVKKSQMPKFSMGT---EITTVSSG-KKRKFEDDEQTFTLTVRGRENYDMLCKIRDSLEIAALLPQNQL 
Ssp73        ACPGRDRKGDEKGM--LPQSPQS-KKNGAMPRLTIGT---EITTVTSG-KKRKFESDNDTYTLTVRGLENYQMLCKIRDSLEIASLLPQNQI 
Hsp73a       ACPGRDRKADEDHYREQQALNESSAKNGAASKRAFKQSPPAVPALGAGVKKRRHGDE-DTYYLQVRGRENFEILMKLKESLELMELVPQPLV 
HsdNp73a     ACPGRDRKADEDHYREQQALNESSAKNGAASKRAFKQSPPAVPALGAGVKKRRHGDE-DTYYLQVRGRENFEILMKLKESLELMELVPQPLV 
Mmp73a       ACPGRDRKADEDHYREQQALNESTTKNGAASKRAFKQSPPAIPALGTNVKKRRHGDE-DMFYMHVRGRENFEILMKVKESLELMELVPQPLV 
MmdNp73      ACPGRDRKADEDHYREQQALNESTTKNGAASKRAFKQSPPAIPALGTNVKKRRHGDE-DMFYMHVRGRENFEILMKVKESLELMELVPQPLV 
             .370.......380.......390.......400.......410.......420.......430.......440.......450........ 
 
    NLS 
Mep63/p73    DVYK-QKQLDTNRQSS---PTTSTARVVTLPTHDNTPITIQG------EGRQTTLPFTADLNGQVTSS---QNGVVENHGNIKEELMAN--- 
MedNp63/p73  DVYK-QKQLDTNRQSS---PTTSTARVVTLPTHDNTPITIQG------EGRQTTLPFTADLNGQVTSS---QNGVVENHGNIKEELMAN--- 
Mtp63/p73    DVYK-QKQLDTNRQSS---PTT--ARVVTLPTHDNTPITIQG------EGRQTTLPFTADLNGQVTSS---QNGVVENHGNIKEELMAN--- 
MtdNp63/p73  DVYK-QKQLDTNRQSS---PTT--ARVVTLPTHDNTPITIQG------EGRQTTLPFTADLNGQVTSS---QNGVVENHGNIKEELMAN--- 
Map73        QSLK-QKQVEVQRQSSSIQAATSSARIPAIAATPATTYVQQGVTTTSSDGKQLTMPFNTQELVQVTSSDVSHDGAVPQP--IKEETIQN--D 
Ssp73        DLYK-QKQVEVQRQPS------TSARVLAVPASQAGQVVPQ----TTPELRQDTQPFVSQV-------------EVPQP--IKEETITENGE 
Hsp73a       DSYRQQQQ--LLQRPSHLQPPSYGPVLSPMNKVHGGMNKLPSVNQLVGQPPPHSSAATPNLGPVGPGMLNNHGHAVPANGEMSSSHSAQSMV 
HsdNp73a     DSYRQQQQ--LLQRPSHLQPPSYGPVLSPMNKVHGGMNKLPSVNQLVGQPPPHSSAATPNLGPVGPGMLNNHGHAVPANGEMSSSHSAQSMV 
Mmp73a       DSYRQQQQQQLLQRPSHLQPPSYGPVLSPMNKVHGGVNKLPSVNQLVGQPPPHSSAAGPNLGPMGSGMLNSHGHSMPANGEMNGGHSSQTMV 
MmdNp73      DSYRQQQQQQLLQRPSHLQPPSYGPVLSPMNKVHGGVNKLPSVNQLVGQPPPHSSAAGPNLGPMGSGMLNSHGHSMPANGEMNGGHSSQTMV 
             461......470.......480.......490.......500.......510.......520.......530.......540.......550 
 
       SAM 
Mep63/p73    ------------GDHSISNWLTTLGLSAYIDNFHQQNLFTMEQLDDFTVEDLQKMRIGTSHRNKIWKALVEFHS---------------ESI 
MedNp63/p73  ------------GDHSISNWLTTLGLSAYIDNFHQQNLFTMEQLDDFTVEDLQKMRIGTSHRNKIWKALVEFHS---------------ESI 
Mtp63/p73    ------------GDHSISNWLTTLGLSAYIDNFHQQNLFTMEQLDDFTVEDLQKMRIGTSHRNKIWKALVEFHS---------------ESI 
MtdNp63/p73  ------------GDHSISNWLTTLGLSAYIDNFHQQNLFTMEQLDDFTVEDLQKMRIGTSHRNKIWKALVEFHS---------------ESI 
Map73        M-----------QDNSVSTWLNALGLGAYIDGFHEQNLYSLLQLDDFSLDDLAKMKIGNSHRNKIWKSLLELRN---------------QGF 
Ssp73        M-----------TDISVAAWLNHLGLGAYIDSFHEHNLFSVIQLDDFSLDDLAKMKIGNAHRNKIWKSVLELRN---------------EGL 
Hsp73a       SGSHCTPPPPYHADPSLVSFLTGLGCPNCIEYFTSQGLQSIYHLQNLTIEDLGALKIPEQYRMTIWRGLQDLKQGHDYSTAQQLLRSS-NAA 
HsdNp73a     SGSHCTPPPPYHADPSLVSFLTGLGCPNCIEYFTSQGLQSIYHLQNLTIEDLGALKIPEQYRMTIWRGLQDLKQGHDYSTAQQLLRSS-NAA 
Mmp73a       SGSHCTPPPPYHADPSLVSFLTGLGCPNCIECFTSQGLQSIYHLQNLTIEDLGALKVPDQYRMTIWRGLQDLKQSHDCG--QQLLRSSSNAA 
MmdNp73      SGSHCTPPPPYHADPSLVSFLTGLGCPNCIECFTSQGLQSIYHLQNLTIEDLGALKVPDQYRMTIWRGLQDLKQSHDCG—-QQLLRSSSNAA 
             .......560.......570.......580.......590.......600.......610.......620.......630.......640.. 
 
      HOMO        HOMO  SUMO SUMO 
Mep63/p73    TISDSQ--SLQRDVSTASTISMTSQASISQNSQNSTYCPGYYEVTRYTFKHTV-----SYTKVDERSPKRAKVD--------- 
MedNp63/p73  TISDSQ--SLQRDVSTASTISMTSQASISQNSQNSTYCPGYYEVTRYTFKHTV-----SYTKVDERSPKRAKVD--------- 
Mtp63/p73    TISDSQ--SLQRDVSTASTISMTSQASISQNSQNSTYCPGYYEVTRYTFKHTV-----SYTKVDERSPKRAKVD--------- 
MtdNp63/p73  TISDSQ--SLQRDVSTASTISMTSQASISQNSQNSTYCPGYYEVTRYTFKHTV-----SYTKVDERSPKRAKVD--------- 
Map73        TTAESQ-DSLAKQASSTSTISLASQGSISQ---NSTYNPGFYEVTRHTFKHTI-----SLTKEERHVQTRSSASKAD------ 
Ssp73        TAIQADSQDLQKNASSTSTLSITSQNSVSQ---NSTYNPGYYEVTRYTFKHTI-----SLTAEEKKLQELSPPTKKEKLSTDV 
Hsp73a       TISIGGSGELQRQRVMEAVHFRVRHTITIPNRGGPGG--GPDEWADFGFDLPDCKARKQPIKEEFTEAEIH------------ 
HsdNp73a     TISIGGSGELQRQRVMEAVHFRVRHTITIPNRGGPGG--GPDEWADFGFDLPDCKARKQPIKEEFTEAEIH------------ 
Mmp73a       TISIGGSGELQRQRVMEAVHFRVRHTITIPNRGGAGAVTGPDEWADFGFDLPDCKSRKQPIKEEFTETESH------------ 
MmdNp73      TISIGGSGELQRQRVMEAVHFRVRHTITIPNRGGAGAVTGPDEWADFGFDLPDCKSRKQPIKEEFTETESH------------ 
             .....650.......660.......670.......680.......690.......700.......710.......720..... 
 
 
 
 
 
 
 
Figure 3 
 
 
MedNp63/p73 ------------------------------------------------------------------------------------------ 
TA
Mep63/p73   MPSQMNGDLHNTPQVPIWNSRPDPRLNYLRSQGYNNYNMPSHNYNPGCRFGKFTHHHPIMSQASVSTTCTPSGPPMSQETFEYLWNTLGE 
Mep53       -----------------------------------------------------------MSQASVSTTCTPSGPPMSQETFEYLWNTLGE 
            1........10........20........30........40........50........60........70........80......... 
 
 
MedNp63/p73 --------------------------------MIKFERTGFTTYRLNPIIGQTTTASSMSPDSQTNIIGSSASSPYNDTITSPPPYSPHT 
Mep63/p73   VTQEGGYTNITSKESIDYAFSEAEDETSISVEKYRITSNDSISDLLNPIIGQTTTASSMSPDSQTNIIGSSASSPYNDTITSPPPYSPHT 
Mep53       VTQEGGYTNITSKESIDYAFSEAEDETSISVEKYRITSNDSISDLLNPIIGQTTTASSMSPDSQTNIIGSSASSPYNDTITSPPPYSPHT 
                                                         ********************************************* 
            91.......100.......110.......120.......130.......140.......150.......160.......170........ 
 
 
MedNp63/p73 SMQSPIPSVPSNTDYPGDYGFTISFSQPSKETKSTTWTYSESLKKLYVRMATTCPIRFKCLRQPPQGCVIRAMPIFMKPEHVQEPVKRCP 
DBD II DBD III
Mep63/p73   SMQSPIPSVPSNTDYPGDYGFTISFSQPSKETKSTTWTYSESLKKLYVRMATTCPIRFKCLRQPPQGCVIRAMPIFMKPEHVQEPVKRCP 
Mep53       SMQSPIPSVPSNTDYPGDYGFTISFSQPSKETKSTTWTYSESLKKLYVRMATTCPIRFKCLRQPPQGCVIRAMPIFMKPEHVQEPVKRCP 
            ****************************************************************************************** 
            181......190.......200.......210.......220.......230.......240.......250.......260........ 
 
 
MedNp63/p73 NHATSKEHNENHPAPTHLCRCEHKLAKFVEDPYTSRQSVLIPHEIPQAGSEWVTNLFQFMCLGSCVGGPNRRPIQIVLTLEKDNQVLGRR 
DBD IV 
Mep63/p73   NHATSKEHNENHPAPTHLCRCEHKLAKFVEDPYTSRQSVLIPHEIPQAGSEWVTNLFQFMCLGSCVGGPNRRPIQIVLTLEKDNQVLGRR 
Mep53       NHATSKEHNENHPAPTHLCRCEHKLAKFVEDPYTSRQSVLIPHEIPQAGSEWVTNLFQFMCLGSCVGGPNRRPIQIVLTLEKDNQVLGRR 
            ****************************************************************************************** 
            271......280.......290.......300.......310.......320.......330.......340.......350........ 
 
 
MedNp63/p73 AVEVRICACPGRDRKADEKAALPPCKQSPKKGQKVNIINEITTVTPGGKKRKAEDEPFTLSVRGRENYEILCRLRDSLELSSMVPQNQID 
DBD V NLS OLIGO 
Mep63/p73   AVEVRICACPGRDRKADEKAALPPCKQSPKKGQKVNIINEITTVTPGGKKRKAEDEPFTLSVRGRENYEILCRLRDSLELSSMVPQNQID 
Mep53       AVEVRICACPGRDRKADEKAALPPCKQSPKKGQKVNIINEITTVTPGGKKRKAEDEPFTLSVRGRENYEILCRLRDSLELSSMVPQNQID 
            ****************************************************************************************** 
            361......370.......380.......390.......400.......410.......420.......430.......440........ 
 
 
MedNp63/p73 VYKQKQLDTNRQSSPTTSTARVVTLPTHDNTPITIQGEGRQTTLPFTADLNGQVTSSQNGVVENHGNIKEELMANGDHSISNWLTTLGLS 
NLS SAM
Mep63/p73   VYKQKQLDTNRQSSPTTSTARVVTLPTHDNTPITIQGEGRQTTLPFTADLNGQVTSSQNGVVENHGNIKEELMANGDHSISNWLTTLGLS 
Mep53       VYKQKQLDTNRQWLSMILARENKNKLMKKVKRPQHRPGIKSRT----------------------------------------------- 
            ************ 
            451......460.......470.......480.......490.......500.......510.......520.......530........ 
 
 
MedNp63/p73 AYIDNFHQQNLFTMEQLDDFTVEDLQKMRIGTSHRNKIWKALVEFHSESITISDSQSLQRDVSTASTISMTSQASISQNSQNSTYCPGYY 
SAM 
Mep63/p73   AYIDNFHQQNLFTMEQLDDFTVEDLQKMRIGTSHRNKIWKALVEFHSESITISDSQSLQRDVSTASTISMTSQASISQNSQNSTYCPGYY 
Mep53       ------------------------------------------------------------------------------------------ 
            541......550.......560.......570.......580.......590.......600.......610.......620........ 
 
 
MedNp63/p73 EVTRYTFKHTVSYTKVDERSPKRAKVD 
HOMO SUMO SUMO
Mep63/p73   EVTRYTFKHTVSYTKVDERSPKRAKVD 
Mep53       --------------------------- 
            631......640.......650..... 
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  Figure 6 
A 
 
Variant A 
AAAAA“proximal” 
 
 
Variant B AAAAA“distal” 
 
 
 
B 
 
Mep63/p73a TGATATGCTGAAGACTTATGCCACAACCAAACTAGGCTTGATATGATTGGTCAGTCCTTTACTGTGTAT 
Mep63/p73b TGATATGCTGAAGACTTATGCCACAACCAAACTAGGCTTGATATGATTGGTCAGTCCTTTACTGTGTAT 
           ********************************************************************* 
 
Mep63/p73a TGGACTGACATATATAGAGCAAATGCAATATGGTGCACAAATCAATGTCTAAATGAAGACATTGTAATC 
Mep63/p73b TGGACTGACATATATAGAGCAAATGCAATATGGTGCACAAATCAATGTCTAAATGAAGACATTGTAATC 
           ********************************************************************* 
 
Mep63/p73a TGATATTTTGTTAGACCGCCTGTTTTTAATGCAAATGTTAGATTCTGTCATGTGACCTGTATGGACCTA 
Mep63/p73b TGATATTTTGTTAGACCGCCTGTTTTTAATGCAAATGTTAGATTCTTTTATGTGACCTGTATGGACCTA 
           ********************************************** * ******************** 
 
Mep63/p73a TTATTGATTTGAAATGGCTATTTATTAAACCGATGATGATATGTAAAAATGTTGGTTTATTTCTTAGTT 
Mep63/p73b TTATTGATTTGAAATGGCTATTTATTAAACCGATGATGATGCGTAAAAATGTTGGTTTATTTCTTAGTT 
           ***************************************** *************************** 
 
Mep63/p73a CTCTTTATCTTCAAATACTATATGTTTTCTATTGCAGTTTAAGATTAAATGGCATATCAAATTTCAAAG 
Mep63/p73b CTCTTTATCTTTAACTTCTGTATGTTTTCTATTGCAGTTTAAGATTAAATGGCATATCAAATTTCAAAG 
           *********** ** * ** ************************************************* 
 
Mep63/p73a CATATCCACTTATCTTAATTAAATTGCAGATTTTTTTACTGCAAAACAGGTACAAATATGTTTAAAATG 
Mep63/p73b CATGACCACTTATCTTAATTAAATTGCAGATTTTTTTACTGCAAAACAGTTACAAGTATATTTAAAATG 
           ***  ******************************************** ***** *** ********* 
 
Mep63/p73a TTTGTTGAAAGCCTTTGAATAAAAAAAAAAAAAAAAAAAAAAAAAA 
Mep63/p73b TTTGTTGAAAGCCTTTGAATAAAAAAAAATAGCCACTGAACCAAACATTCTAGGCCTTTATGTGTAACTT 
           *****************************                                          
 
Mep63/p73b TTTTCAACTGTTAACTAGTTAACTGGACCATTAATAAAAATCTATTTATAACACGTAATTATGCTTCTAA 
           TAATTTTAACAATAGGTGCTTAGACATAACACTTAAGATTATTATTAAAATGGCCTTTAAATTTATGTCC 
           ATTCTGGGTGTTATTGTTGATGGAGAAAACAATGGAATGCCTGTTTTCTGAATGTTGTTGATTATATTAT 
           ATATATATATATATGCATTTTGTCTGTTGTTCTGCTGAGATCAAGTTCAGGGTAGAATTTCTGCAATTGT 
           ATTCATTTCAAGATTTCCACTAAATTCCATAGTAGGAATTTCATAATGAGGCTCAAAATTCCATAGTGAG 
           GCTTAGTATGTCATTTGCAAAAGATTGTTGTCATTAGTAACTGCCATGTAGCATTTTGCAGAAGAACTAC 
           TCTGAGCTAGTGTGAGTTATAACAATAATAGTGTTCAAATTTTATGATAAAACTATGTGTTCAGAATTAT 
           CATGTAAACATCGAACTTTAAAAGTGTTCAACATTAAATTCATTTGCATTCATGTATATCGTTTTGTTTT 
           TTTAACTGCTGATTTTGCAACAGTGCTATAAAATTGAATCAAATATTTTGCAAAATGGGGATATATTATT 
           TCCCTCATAATTTCATTAATTAGTATTGTTCACCTTATGTCCTCTAAAGATGCTCATAGGTTGTTTCCAA 
           GCTGAATTTTTTTGTAATCTGTTTTTAGGAAATTGGCAAAACTTGTCAAAAGAACTTCTTTTATAAAATG 
           GGAATAAACTCAAATCATTTTGTGTATAATTATCAATGAAAACAACATTCACAGGTGGACATCCATTTGT 
           TATAATTTTTTCATAAATTCCAGGGATGAAATTTGTTCCTCCAAGGAAATTGACTTCATAATCATTCCAT 
           TGCCACCATTGTAATTCATTCTGTTTCCGTCCAAATACATGCGTGTGTTCTTTTGTTCATGCAACTACAA 
           ATTANTGGCTATTTATCTGTTTAATTAAACATTACTAGTTTATTTATTTAAACATCTCGAAAAAAAAAAA 
           AAAAAAAAAAAAAAAAAA 
Table 1: 
Reaction Forward primer (5’->3’) Reverse primer (5’->3’) approximate 
product size (nt) 
 
ITS-PCR 
 
 
gtttccgtaggtgaacctg 
 
ctcgtctgatctgaggtcg 
 
1250 
Degenerate 
PCR 
 
pMe-1F: 
atgtcacaagcttcagtttcaac 
pDeg-p73R(1698-1716): 
ttccaDatYttRttHcKYtg 
1600 
3’ RACE p3’RACE-p73-1: 
gtgaaggtcggcagacgacactaccg 
 
n.a. 2500 and 1000 
5’ RACE n.a. 
 
p5’RACE-p73-1: 
cggtagtgtcgtctgccgaccttcac 
 
1800, (1600, 1400) 
Full-length 
p63/p73 A 
M. trossulus, pp73-2F: 
atgaatggggatttacacaatacacc 
 
M. edulis, pp73-1F: 
atgccgtctcaaatgaatggg 
M. trossulus, pp73UTRa-R2: 
taaattcaaaagctttaagcaaacattttaaac 
 
M. edulis, pMep73a-R1: 
ggctttcaacaaacattttaaacatatttg 
 
2440 
 
 
2500 
Full-length 
p63/p73 B 
pp73-1F: 
atgccgtctcaaatgaatggg 
 
pp73-1F: 
atgccgtctcaaatgaatggg 
M. trossulus, pp73UTR-R2: 
ttcttccttagtagcaagc 
 
M.edulis, pMep73b-R2: 
ttgcatgaacaaaagaacacacg 
 
3700 
 
 
4000 
 
Full-length 
DeltaN 
p63/p73 A 
pdNp73F: 
atgatcaaatttgagagaactgg 
 
pdNp73F: 
atgatcaaatttgagagaactgg 
M. trossulus, pp73UTRa-R2: 
taaattcaaaagctttaagcaaacattttaaac 
 
M. edulis, pMep73a-R1: 
ggctttcaacaaacattttaaacatatttg  
 
2080 
 
 
2000 
Full-length 
DeltaN 
p63/p73 B 
pdNp73F: 
atgatcaaatttgagagaactgg 
 
pdNp73F: 
atgatcaaatttgagagaactgg 
M. trossulus, pp73UTR-R2: 
ttcttccttagtagcaagc 
 
M.edulis, pMep73b-R2: 
ttgcatgaacaaaagaacacacg 
 
3340 
 
 
3060 
Colonie 
screen  
M13 F (-20): 
gtaaaacgacggccag 
M13 R: 
caggaaacagctatgac 
n.a. 
Table 2: 
Abbreviation Scientific species name and cDNA designation Accession number Phylogenetic taxa 
Mep53 Mytilus edulis p53 homologue AY579472 Invertebrate, Mollusca 
Mep63/p73 Mytilus edulis p63/p73 homologue, variant B (distal) DQ060435 Invertebrate, Mollusca 
MedNp63/p73 Mytilus edulis DeltaNp63/p73 homologue, variant B (distal) DQ060436 Invertebrate, Mollusca 
Mep63/p73 Mytilus edulis p63/p73 homologue, variant A (proximal) DQ865150 Invertebrate, Mollusca 
MedNp63/p73 Mytilus edulis DeltaNp63/p73 homologue, variant A (proximal) DQ865151 Invertebrate, Mollusca 
Mtp53 Mytilus trossulus p53 homologue AY611471 Invertebrate, Mollusca 
Mtp63/p73 Mytilus trossulus p63/p73 homologue, variant B (distal) DQ060437 Invertebrate, Mollusca 
MtdNp63/p73 Mytilus trossulus DeltaNp63/p73 homologue, variant B (distal) DQ060438 Invertebrate, Mollusca 
Mtp63/p73 Mytilus trossulus p63/p73 homologue, variant A (proximal) DQ865152 Invertebrate, Mollusca 
MtdNp63/p73 Mytilus trossulus DeltaNp63/p73 homologue, variant A (proximal) DQ865153 Invertebrate, Mollusca 
Map53 Mya arenaria p53 homologue AF253323 Invertebrate, Mollusca 
Map73 Mya arenaria p73 homologue AF253324 Invertebrate, Mollusca 
Ssp73 Spisula solidissima p63/p73 homologue AY289768 Invertebrate, Mollusca 
Drp53 Danio rerio p53 AF365873 Vertebrate, Ostariophysi 
Drp73 Danio rerio tumor protein p73-like, transcript variant alpha 1 NM_152986 Vertebrate, Ostariophysi 
Bbp53 Barbus barbus p53 AF071570 Vertebrate, Ostariophysi 
Bbp73 Barbus barbus p73 AF043641 Vertebrate, Ostariophysi 
Xlp53 Xenopus laevis tumor supressor protein p53 AY221266 Vertebrate, Amphibian 
Xlp63 Xenopus laevis p63 DNA binding protein AF314148 Vertebrate, Amphibian 
Ggp53 Gallus gallus tumor protein p53 NM_205264 Vertebrate, Aves 
Ggp63 Gallus gallus transformation related protein Trp63 NM_204351 Vertebrate, Aves 
GgdNp63 Gallus gallus DeltaN p63 alpha AB045224 Vertebrate, Aves 
Ggp73prd Gallus gallus similar to P73 alpha protein (predicted) XM_417545 Vertebrate, Aves 
Hsp53 Homo sapiens p53 AB082923 Vertebrate, Mammal 
Hsp63a Homo sapiens TA p63 alpha AF075430 Vertebrate, Mammal 
HspdNp63a Homo sapiens DeltaN p63 alpha AF075431 Vertebrate, Mammal 
Hsp73 Homo sapiens p73 alpha NM_005427 Vertebrate, Mammal 
HspdNp73a Homo sapiens DeltaNp73 alpha AB055065 Vertebrate, Mammal 
Rnp53 Rattus norvegicus tumor protein p53 (Tp53) NM_030989 Vertebrate, Mammal 
Rnp73prd Rattus norvegicus transformation related protein 73 (predicted) XM_342992 Vertebrate, Mammal 
Mmp53 Mus musculus transformation associated protein p53 X00741 Vertebrate, Mammal 
Mmp63 Mus musculus transformation related protein Trp63 NM_011641 Vertebrate, Mammal 
Mmp73a Mus musculus p73 alpha MMY9234 Vertebrate, Mammal 
MmdNp73 Mus musculus DeltaNp73 MMU19235 
 
Vertebrate, Mammal 
